Persones / Equip Humà

Angel Montero Carcaboso

Buscador de publicacions

Publicacions

  • Monterrubio C, Paco-Mercader S, Vilà-Ubach M, Rodriguez E, Glisoni R, Lavarino C, Schaiquevich P, Sosnik A, Mora J and Carcaboso AM.

    Combined Microdialysis-Tumor Homogenate Method for the Study of the Steady State Compartmental Distribution of a Hydrophobic Anticancer Drug in Patient-Derived Xenografts

    PHARMACEUTICAL RESEARCH . 32(9): 2889-2900. Nº de cites: 10

    [doi:10.1007/s11095-015-1671-9]

  • Ordóñez JL, Amaral AT, Carcaboso AM, Herrero-Martín D, Del Carmen García-Macías M, Sevillano V, Alonso D, Pascual-Pastó G, San-Segundo L, Vilà-Ubach M, Rodrigues T, Fraile S, Teodosio C, Mayo-Iscar A, Aracil M, Galmarini CM, Tirado OM, Mora J and de Álava E.

    The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin

    Oncotarget . 6(22): 18875-18890. Nº de cites: 64

    [doi:10.18632/oncotarget.4303]

  • Cockle JV, Picton S, Levesley J, Ilett E, Carcaboso AM, Short S, Steel LP, Melcher A, Lawler SE and Brüning-Richardson A.

    Cell migration in paediatric glioma; characterisation and potential therapeutic targeting

    BRITISH JOURNAL OF CANCER . 112(4): 693-703. Nº de cites: 25

    [doi:10.1038/bjc.2015.16]

  • Schaiquevich P, Carcaboso AM, Buitrago E, Taich P, Opezzo J, Bramuglia G and Chantada GL.

    OCULAR PHARMACOLOGY OF TOPOTECAN AND ITS ACTIVITY IN RETINOBLASTOMA

    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES . 34(9): 1719-1727. Nº de cites: 31

    [doi:10.1097/IAE.0000000000000253]

  • Sosnik A and Carcaboso AM.

    Nanomedicines in the future of pediatric therapy

    ADVANCED DRUG DELIVERY REVIEWS . 73: 140-161. Nº de cites: 47

    [doi:10.1016/j.addr.2014.05.004]

  • Parareda A, Català-Mora J, Carcaboso AM, Sola T, Cruz-Martínez O, Díaz J, Salvador-Hernandez H, de Torres C, Álvarez-Sampons A, Suñol M, Vinent J, Guimaraens L, Prat-Bartomeu J and Mora J.

    Intra-arterial chemotherapy for retinoblastoma. Challenges of a prospective study

    ACTA OPHTHALMOLOGICA . 92(3): 209-215. Nº de cites: 27

    [doi:10.1111/aos.12295]

  • Taylor KR, Mackay A, Truffaux N, Butterfield YS, Morozova O, Philippe C, Castel D, Grasso CS, Vinci M, Carvalho D, Carcaboso AM, de Torres C, Cruz-Martínez O, Mora J, Entz-Werle N, Ingram WJ, Monje M, Hargrave D, Bullock AN, Puget S, Yip S, Jones C and Grill J.

    Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma

    NATURE GENETICS . 46(5): 457-461. Nº de cites: 412

    [doi:10.1038/ng.2925]

  • Elmeliegy MA, Carcaboso AM, L Chow LM, Zhang ZM, Calabrese C, Throm SL, Wang F, Baker SJ and Stewart CF.

    Magnetic Resonance Imaging-Guided Microdialysis Cannula Implantation in a Spontaneous High-Grade Glioma Murine Model

    JOURNAL OF PHARMACEUTICAL SCIENCES . 100(10): 4210-4214. Nº de cites: 9

    [doi:10.1002/jps.22723]

  • Atkinson JM, Shelat AA, Carcaboso AM, Kranenburg TA, Arnold LA, Boulos N, Wright K, Johnson RA, Poppleton H, Mohankumar KM, Féau C, Phoenix T, Gibson P, Zhu L, Tong Y, Eden C, Ellison DW, Priebe W, Koul D, Yung WK, Gajjar A, Stewart CF, Guy RK and Gilbertson RJ.

    An Integrated In Vitro and In Vivo High-Throughput Screen Identifies Treatment Leads for Ependymoma

    Cancer Cell . 20(3): 384-399. Nº de cites: 94

    [doi:10.1016/j.ccr.2011.08.013]

  • Nemeth KM, Federico S, Carcaboso AM, Shen Y, Schaiquevich P, Zhang J, Egorin M, Stewart C and Dyer MA.

    Subconjunctival Carboplatin and Systemic Topotecan Treatment in Preclinical Models of Retinoblastoma

    CANCER . 117(2): 421-434. Nº de cites: 44

    [doi:10.1002/cncr.25574]